Ambeed.cn

首页 / / / / XAV-939

XAV-939 {[allProObj[0].p_purity_real_show]}

货号:A180960 同义名: NVP-XAV939

XAV-939是一种 Tankyrase 抑制剂,可作为细胞疗法中的辅助试剂。XAV939诱导由小鼠胚胎干细胞衍生的中胚层祖细胞的心肌生成,与 SMAD 抑制剂 LDN193189 和 SB431542 联合使用,促进人类多能干细胞系中前脑的诱导。

XAV-939 化学结构 CAS号:284028-89-3
XAV-939 化学结构
CAS号:284028-89-3
XAV-939 3D分子结构
CAS号:284028-89-3
XAV-939 化学结构 CAS号:284028-89-3
XAV-939 3D分子结构 CAS号:284028-89-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

XAV-939 纯度/质量文件 产品仅供科研

货号:A180960 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 PARP PARP1 PARP2 PARP3 其他靶点 纯度
PJ34 HCl ++

PARP, EC50: 20 nM

99%+
Rucaparib phosphate ++++

PARP, Ki: 1.4 nM

99%+
3-Aminobenzamide ++

PARP, IC50: <50 nM

98%
AZD-2461 99%+
BGP-15 99%+
NU1025 +

PARP, IC50: 400 nM

98%
Benzamide +

PARP, IC50: 3.3 μM

98%
Picolinamide +

PARP, IC50: 95 μM

98%
AG14361 +++

PARP1, Ki: <5 nM

98+%
Iniparib 98%
Talazoparib ++++

PARP1, IC50: 0.57 nM

99%+
NMS-P118 ++

PARP1, Kd: 0.009 μM

97%
UPF 1069 +

PARP1, IC50: 8.0 μM

++

PARP2, IC50: 0.3 μM

98%
A-966492 ++++

PARP1, Ki: 1 nM

PARP1, EC50: 1 nM

+++

PARP2, Ki: 1.5 nM

99%+
Veliparib ++

PARP1, Ki: 5.2 nM

+++

PARP2, Ki: 2.9 nM

98%
Niraparib tosylate +++

PARP1, IC50: 3.8 nM

+++

PARP2, IC50: 2.1 nM

99%+
Stenoparib ++++

PARP1, IC50: 1 nM

++++

PARP2, IC50: 1.2 nM

98%
Olaparib +++

PARP1, IC50: 5 nM

++++

PARP2, IC50: 1 nM

98%
Niraparib +++

PARP1, IC50: 3.8 nM

+++

PARP2, IC50: 2.1 nM

98%
ME0328 +

PARP1, IC50: 6.3 μM

+

PARP3, IC50: 0.89 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

XAV-939 生物活性

描述 Poly (ADP-ribose) polymerase (PARP) 1 is an essential molecule in DNA damage response by sensing DNA damage and docking DNA repair proteins on the damaged DNA site through a type of posttranslational modification, poly (ADP-Ribosyl)ation (PARylation). PARP inhibitors, which inhibit PARylation through competitively binding to NAD+ binding site of PARP1 and PARP2, have improved clinical benefits for BRCA mutated tumors, leading to their accelerated clinical application[3]. XAV-939 is a potent tankyrase inhibitor that targets Wnt/β-catenin signaling. XAV-939 stabilizes axin by inhibiting tankyrase 1 and tankyrase 2 (IC50s of 5 and 2 nM, respectively), thereby stimulating β-catenin degradation. XAV939 binds tightly to the catalytic (PARP) domains of TNKS1 and TNKS2 (Kds of 99 and 93 nM, respectively)[4].XAV939 (0.5 μM, 1.0 μM) reduces DNA-PKcs protein levels 50% of the relative DMSO control in human lymphoblasts[5]. XAV939 induces a second wave of pro-cardiomyocyte gene expression as shown by increased Mesp1 and Isl1expression 2 to 4 days after Wnt inhibition, and by increased Nkx2.5 expression 4 to 6 days after XAV939 addition[6]. XAV-939 (10 nM) has a suppressive effect on elevated MMP-13 levels in both IL-1β-induced SW 1353 cells. XAV-939 (3 mL, 10 nM) has a suppressive effect on elevated MMP-13 levels in the rat OA model[7].XAV-939(1mg/mL,i.p.) ameliorates the psoriasiform skin disease induced by IMQ. XAV-939 results in a significant decrease in the IMQ-induced epidermal hyperplasia (indicated by acanthosis) and dermal inflammatory infiltrates in mice[8].

XAV-939 细胞实验

Cell Line
Concentration Treated Time Description References
human pluripotent stem cell-derived GnRH neurons 10 µM 10 days To investigate the effect of Wnt signaling inhibition on GnRH neuron differentiation, it was found that Wnt inhibition significantly improved the differentiation efficiency of GnRH neurons Stem Cells. 2022 Dec 31;40(12):1107-1121.
pancreatic progenitor cells 5 µM 4 days To inhibit the WNT signaling pathway and study its effect on the differentiation of FOXA2-deficient pancreatic progenitor cells. The results showed that WNT inhibition partially reversed the phenotype associated with FOXA2 deficiency. Cell Death Dis. 2021 Jan 20;12(1):103.
Mouse epiblast stem cells (EpiSCs) 10 µM XAV-939 promotes the stable maintenance of EpiSCs by inhibiting the Wnt signaling pathway and reducing spontaneous differentiation. Stem Cell Reports. 2015 Apr 14;4(4):744-57.
MDA-MB-231 5 μM 48 h Inhibition of cell proliferation J Transl Med. 2013 Nov 4;11:280.
HCC-1937 5 μM 48 h Inhibition of cell proliferation J Transl Med. 2013 Nov 4;11:280.
HCC-1143 5 μM 48 h Inhibition of cell proliferation J Transl Med. 2013 Nov 4;11:280.
BT-549 5 μM 48 h Inhibition of cell proliferation J Transl Med. 2013 Nov 4;11:280.
OPCs 0.5 μM 3 days XAV-939 significantly rescued Mbp expression and OL morphology in the Eed null OL lineage Cell Rep. 2020 Sep 15;32(11):108147.
mouse oligodendrocyte progenitor cells 0.01 or 0.1μM 24 h increased levels of both Axin2 and Axin1 proteins, promoted oligodendrocyte differentiation Nat Neurosci. 2011 Jun 26;14(8):1009-16.
fibroblasts 10 µM DPC-Exos attenuated the inhibitory effect of XAV939, leading to an increase in the expression levels of these molecules. J Nanobiotechnology. 2024 Jul 19;22(1):425.
fibroblasts 10 µM XAV939 significantly inhibited the proliferation and migration of fibroblasts, suggesting that blocking the Wnt/β-catenin signaling pathway could hinder the activity of fibroblasts. J Nanobiotechnology. 2024 Jul 19;22(1):425.

XAV-939 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mkx+/- mouse Achilles tendon injury model Local injection 4 µM Single administration, observed for 28 or 52 days XAV-939 improved tendon regeneration in mice by inhibiting the Wnt/β-Catenin signaling pathway, reducing fibrosis and angiogenesis, and enhancing biomechanical properties. Sci Rep. 2022 Nov 21;12(1):20003
Mouse Spinal cord demyelination model Spinal cord injection 0.1μM Single injection, duration of 6 days Accelerated oligodendrocyte progenitor cell differentiation and myelin regeneration Nat Neurosci. 2011 Jun 26;14(8):1009-16.
Mice Full-thickness skin excision model Intraperitoneal injection 1.25 mg/kg Four injections on day 1 After treatment with XAV939, wound closure was significantly slower compared to other groups, suggesting that blocking the Wnt/β-catenin signaling pathway could impede wound healing. Specifically, the wound closure rate and the number of new HFs in DPC-Exos + X group was significantly reduced compared to the DPC-Exos group, which suggested that blocking the Wnt/β-catenin signaling pathway could inhibit the promoting effects of DPC-Exos on wound healing and HF regeneration. J Nanobiotechnology. 2024 Jul 19;22(1):425.

XAV-939 参考文献

[1]Ahrum Min ,et al. PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation. Cancers (Basel). 2020 Feb 8;12(2):394.

[2] Huang SM, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009 Oct 1;461(7264):614-620.

[3] Ahrum Min ,et al. PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation. Cancers (Basel). 2020 Feb 8;12(2):394.

[4] Huang SM, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009 Oct 1;461(7264):614-620.

[5]Dregalla RC, et al. Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs. Aging (Albany NY). 2010 Oct;2(10):691-708.

[6]Ao A, et al. DMH1, a Novel BMP Small Molecule Inhibitor, Increases Cardiomyocyte Progenitors and Promotes Cardiac Differentiation in Mouse Embryonic Stem Cells.,PLoS One. 2012;7(7):e41627.

XAV-939 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.20mL

0.64mL

0.32mL

16.01mL

3.20mL

1.60mL

32.02mL

6.40mL

3.20mL

XAV-939 技术信息

CAS号284028-89-3
分子式C14H11F3N2OS
分子量 312.31
SMILES Code O=C1C(CSCC2)=C2N=C(C3=CC=C(C(F)(F)F)C=C3)N1
MDL No. MFCD16879017
别名 NVP-XAV939
运输蓝冰
InChI Key KLGQSVMIPOVQAX-UHFFFAOYSA-N
Pubchem ID 135418940
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

溶解方案

DMSO: 15 mg/mL(48.03 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。